$CYTR CYTRX CORP Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in CYTRX CORP.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of insider trading in CYTRX CORP. Insider overview, share value development, latest insider transactions and email notifications about new events in CYTRX CORP for free.

CIK Number: 0000799698
IRS Number: 581642750
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Trading Symbol: CYTR
Company Address: 11726 SAN VICENTE BOULEVARD SUITE 650 LOS ANGELES 90049
Phone number: 310-826-5648

CytRx Corp. is a biopharmaceutical research and development company, which engages in the discovery, research, and clinical development of novel anti-cancer drug candidates. It focuses on developing the Linker Activated Drug Release (LADR) technology platform, a discovery engine to help create a pipeline of anti-cancer molecules that will avoid unacceptable systemic toxicity while delivering highly potent agents directly to the tumor. The company was founded on February 28, 1985 and is headquartered in Los Angeles, CA.

Market Capitalization: $38.92M
Prev close: $0.42
Average Daily Volume: 1,450,350
Days Low: $0.40
Year Low: $0.36
Year High: $3.66

CYTRX CORP Latest Insider Transactions

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Aug 20 2020CYTRCYTRX CORPBrien Earl WDirectorOption ExerciseM0.26150,00039,000300,000
Aug 20 2020CYTRCYTRX CORPBrien Earl WDirectorBuyM0.26150,00039,000590,247440.2 K to 590.2 K (+34.07 %)
Aug 13 2020CYTRCYTRX CORPKRIEGSMAN STEVEN AChief Executive Off ...Option ExerciseM0.263,000,000780,0000
Aug 13 2020CYTRCYTRX CORPKRIEGSMAN STEVEN AChief Executive Off ...Payment of ExerciseF0.671,164,179780,0003,668,0384.8 M to 3.7 M (-24.09 %)
Aug 13 2020CYTRCYTRX CORPKRIEGSMAN STEVEN AChief Executive Off ...BuyM0.263,000,000780,0004,832,2171.8 M to 4.8 M (+163.74 %)
Aug 13 2020CYTRCYTRX CORPIGNARRO LOUISDirectorOption ExerciseM0.26700,000182,0000
Aug 13 2020CYTRCYTRX CORPIGNARRO LOUISDirectorPayment of ExerciseF0.67271,642182,000600,785872.4 K to 600.8 K (-31.14 %)
Aug 13 2020CYTRCYTRX CORPIGNARRO LOUISDirectorBuyM0.26700,000182,000872,427172.4 K to 872.4 K (+405.97 %)
Aug 13 2020CYTRCYTRX CORPCaldwell Joel KDirectorOption ExerciseM0.26450,000117,0000
Aug 13 2020CYTRCYTRX CORPCaldwell Joel KDirectorPayment of ExerciseF0.67174,627117,000335,373510 K to 335.4 K (-34.24 %)
Aug 13 2020CYTRCYTRX CORPCaldwell Joel KDirectorBuyM0.26450,000117,000510,00060 K to 510 K (+750.00 %)
Dec 17 2019CYTRCYTRX CORPKRIEGSMAN STEVEN ACEOOption ExerciseA0.263,000,000780,0003,000,000
Dec 17 2019CYTRCYTRX CORPIGNARRO LOUISDirectorOption ExerciseA0.26700,000182,000700,000
Dec 17 2019CYTRCYTRX CORPCALOZ JOHN YChief Financial Off ...Option ExerciseA0.26350,00091,000350,000
Dec 17 2019CYTRCYTRX CORPCaldwell Joel KDirectorOption ExerciseA0.26450,000117,000450,000

View all CYTRX CORP insider transactions.